EP3363433
Aðferðir til að minnka hættuna á hjarta- og æða-tilviki í einstaklingi sem er í statín-meðferð með því að nota eikósapentensýru-etýlester
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
28.6.2013EP published:
9.12.2020EP application number:
17206714.2
EP translation filed:
20.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
27.6.2033Expiry date:
27.6.2026
Title:
METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY USING EICOSAPENTAENOIC ACID ETHYL ESTER
Timeline
Today
28.6.2013EP application
9.12.2020EP Publication
20.1.2021Translation submitted
15.2.2021Registration published
27.6.2026Expires
Owner
Name:
Amarin Pharmaceuticals Ireland LimitedAddress:
2 Pembroke House Upper Pembroke Street 28-32, Dublin 2, IE
Inventor
Name:
SONI, PareshAddress:
Mystic, CT 06355, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261666447 PDate:
29.6.2012Country:
US
Classification
Categories:
A61K 31/232, A61P 9/00, A61P 9/10, A61K 45/06, A61K 31/397
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 25.5.2021
Expires: 27.6.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 6.5.2022
Expires: 27.6.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.5.2023
Expires: 27.6.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.5.2024
Expires: 27.6.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.6.2025
Expires: 27.6.2026
Payer: Árnason Faktor ehf.